Applied Filters
Biogen blocking bid rejected; signs $2.4bn deal
The US Court of Appeals for the Federal Circuit has rejected Biogen’s bid to block a generic version of its multiple sclerosis drug, pending an appeal against a lower court’s ruling.
Genentech in $1.7bn immuno-oncology deal
California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.
Vir Biotech partners with WuXi on COVID-19 antibody treatment
Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.
GSK and Chinese biotech unite for coronavirus vaccine development
British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.
10x Genomics strikes back in Bio-Rad saga with USITC ban
US biotechnology company 10x Genomics has won an import ban against its rival Bio-Rad Laboratories in a long-running patent dispute.
BMS partners with drug accelerator to launch biotech
Bristol-Myers Squibb and BioMotiv, a drug development accelerator, have launched Anteros Pharmaceuticals, a biotech focused on developing a new class of drugs for fibrotic and other inflammatory diseases.
CIPA and UKIPO join forces to change misleading Brexit advice
The UK Intellectual Property Office and the Chartered Institute of Patent Attorneys have worked together to ensure changes are made to “misleading” advice issued by the EU’s Community Plant Variety Office.
Bristows hires Arnold & Porter partner to boost life sciences team
Arnold & Porter partner Richard Dickinson has joined Bristows as a partner in its commercial and IP transactional practice in London.
Fasken hires Belmore Neidrauer partner
Jason Markwell, a former partner at Belmore Neidrauer, has joined Fasken’s IP group in its Toronto office.
Latham & Watkins boosts team with life sciences litigator
A life sciences litigator from Williams & Connolly has joined Latham & Watkins’ Washington, DC office.
